NMAI vs NPFD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
NMAI presents a stark contradiction between its deterministic health markers and its value profile. The Piotroski F-Score of 1/9 indicates severe fundamental weakness by corporate standards, which heavily weighs down the health assessment. However, the fund is trading at a significant discount to its intrinsic value of $17.01 and offers a robust 10.03% dividend yield with a sustainable payout ratio. While long-term price performance is strong, the current technical trend is sharply bearish (10/100), suggesting a period of consolidation or decline despite the valuation gap.
NPFD exhibits strong fundamental value, trading significantly below its Graham Number ($31.31) and Intrinsic Value ($63.42). The Piotroski F-Score of 6/9 indicates a stable financial health profile, while a Price-to-Book ratio of 0.95 suggests the fund is trading at a discount to its net asset value. Despite a bearish technical trend and a high payout ratio, the combination of a 9.73% yield and strong earnings growth (23.6%) makes it an attractive income-oriented value play.
Compare Another Pair
Related Comparisons
NMAI vs NPFD: Head-to-Head Comparison
This page compares Nuveen Multi-Asset Income Fund (NMAI) and Nuveen Variable Rate Preferred & Income Fund (NPFD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.